Navigation Links
Cyprotex Purchases Applied Biosystems Sciex QTRAP(R) 5500 LC-MS/MS

MACCLESFIELD, England, November 19 /PRNewswire-FirstCall/ -- Cyprotex are proud to announce the introduction in their facilities of one of the most sensitive ion trap and triple quadrupole instruments in the industry.

The QTRAP(R) 5500 LC-MS/MS offers unparalleled sensitivity and impressive speed by uniting the world's most sensitive triple quadrupole with the world's most sensitive and fastest scanning linear ion trap. It combines exceptional quantitative and qualitative analytical potential with no sacrifice in performance for either capability, and allows accurate and precise ion detection over a wide dynamic range.

The introduction of the QTRAP(R) 5500 is part of Cyprotex's expansion of our bioanalytical facility and will enable us to offer a comprehensive bioanalytical method development and validation service as well as an enhanced and highly sensitive metabolite profiling and identification service. The instrument will increase the likelihood of detecting poorly sensitive molecules which are problematic in conventional LC-MS/MS systems.

Dr Anthony Baxter, Cyprotex's Chief Executive Officer, comments on the purchase of the new QTRAP(R) 5500 LC-MS/MS, "Cyprotex will be able to deliver a superior bioanalytical service which will set us apart from many of our competitors. This state of the art technology allows highly sensitive and accurate analysis giving us the very best chance of successfully detecting and quantifying our customers' molecules."

Ian Clarke, Applied Biosystems' Country Commercial Leader UK & Ireland, comments, "The QTRAP(R) 5500 LC-MS/MS has only recently been launched and Cyprotex are the first company in the UK to benefit from this next generation technology. This addition to their facility will greatly enhance Cyprotex's bioanalytical service enabling their customers to access the most sensitive ion trap LC-MS/MS instruments in the industry."

    For further information:
    Cyprotex PLC
    Helen Gill PhD, Product Development Manager
    Tel: +44-1625-505-100

SOURCE Cyprotex Discovery Ltd
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cyprotex Introduces New Product Line Cloe(R) Select - a Portfolio of Bespoke ADME and PK Services
2. Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics
3. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $24.7 Million of Senior Convertible Notes
4. George Washington University Hospital Purchases Orthocrats TraumaCad(TM) for Orthopedic Preoperative Planning
5. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $14.2 Million of Senior Convertible Notes
6. CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million
7. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
8. Enigma Diagnostics Announces Patent Licence With Applied Biosystems
9. Nanoscale carbon materials research wins the 2008 Julius Springer Prize for Applied Physics
10. Applied Computational Technologies Appoints a New CEO
11. Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Pittcon is pleased ... technical presentations offered in symposia, oral sessions, workshops, awards, and posters. The ... range of applications such as, but not limited to, biotechnology, biomedical, drug discovery, ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/24/2015)... 24, 2015  Asia-Pacific (APAC) holds the third-largest ... market. The trend of outsourcing to low-cost locations ... higher volume share for the region in the ... margins in the CRO industry will improve. ... ( ), finds that the market earned ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015 Pressure BioSciences, ... in the development and sale of broadly enabling, pressure ... life sciences industry, today announced it has received gross ... $5 million Private Placement (the "Offering"), increasing the total ...  One or more additional closings are expected in the ...
(Date:11/11/2015)... , Nov. 11, 2015   MedNet Solutions , ... spectrum of clinical research, is pleased to announce that it ... Clinical Trials (PCT) event, to be held November 17-19 ... able to view live demonstrations of iMedNet ... learn how iMedNet has been able to deliver ...
(Date:11/4/2015)... November 4, 2015 --> ... report published by Transparency Market Research "Home Security Solutions Market ... Forecast 2015 - 2022", the global home security solutions market is ... by 2022. The market is estimated to expand at ... 2015 to 2022. Rising security needs among customers at ...
Breaking Biology News(10 mins):